Latest News and Press Releases

Kraig Labs (OTCQB: KBLB) is entering a new phase of commercial scale-up as it accelerates spider silk production to meet growing demand from global brands.

As AI continues to move beyond software and automation, its impact on genomics and gene editing is becoming increasingly tangible

Kraig Labs (OTCQB: KBLB) 2026 production plan will drive explosive growth and establish a new global benchmark for spider silk manufacturing.

Innovation still rules, but ownership of the entire supply-chain pipeline is becoming the next biggest strategic advantage in today’s markets.

President Trump wants to deploy AI systems to hunt fraud, likened in headlines to an AI “Ironman suit”, reigniting interest in advanced technologies

CRISPR and related genome engineering technologies are reshaping industries from medicine to materials, with breakthroughs

Kraig Labs (OTCQB: KBLB) is implementing its most ambitious and advanced genetic engineering initiative ever, to dramatically increase toughness

Kraig Labs (OTCQB: KBLB) will soon deliver its first spider silk fibers to three companies in the fashion and performance textiles sectors.

Kraig Labs (OTCQB: KBLB) added its 3rd silkworm rearing center, completing the infrastructure upgrades for its 2026 spider silk production scale-up

flyExclusive (NYSE American: FLYX), Kraig Labs (OTCQB: KBLB), Aclarion (NASDAQ: ACON), and MoonLake Immunotherapeutics (NASDAQ: MLTX) are today’s leaders